These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18769302)

  • 1. Tumor-specific activation of prodrugs: is there a role for nuclear medicine?
    Antunes IF; Haisma HJ; de Vries EF
    Nucl Med Commun; 2008 Oct; 29(10):845-6. PubMed ID: 18769302
    [No Abstract]   [Full Text] [Related]  

  • 2. Prodrugs.
    Backes WL
    Clin J Oncol Nurs; 2001; 5(1):35. PubMed ID: 11899400
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor targeting: activation of prodrugs by enzyme-monoclonal antibody conjugates.
    Huennekens FM
    Trends Biotechnol; 1994 Jun; 12(6):234-9. PubMed ID: 7765070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-catalyzed activation of anticancer prodrugs.
    Rooseboom M; Commandeur JN; Vermeulen NP
    Pharmacol Rev; 2004 Mar; 56(1):53-102. PubMed ID: 15001663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy.
    Legigan T; Clarhaut J; Tranoy-Opalinski I; Monvoisin A; Renoux B; Thomas M; Le Pape A; Lerondel S; Papot S
    Angew Chem Int Ed Engl; 2012 Nov; 51(46):11606-10. PubMed ID: 22996951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel prodrugs: toward smarter delivery of anticancer agents.
    Skwarczynski M; Hayashi Y; Kiso Y
    J Med Chem; 2006 Dec; 49(25):7253-69. PubMed ID: 17149855
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of prodrugs by targeted enzymes.
    Hellström KE; Senter PD
    Eur J Cancer; 1991; 27(11):1342-3. PubMed ID: 1835844
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-directed enzyme prodrug therapy.
    Connors TA
    Cancer Cells; 1990 Feb; 2(2):56-7. PubMed ID: 2397145
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-directed enzyme/prodrug therapy (ADEPT).
    Bagshawe KD
    Biochem Soc Trans; 1990 Oct; 18(5):750-2. PubMed ID: 2083666
    [No Abstract]   [Full Text] [Related]  

  • 10. Generation of cytotoxic agents by targeted enzymes.
    Senter PD; Wallace PM; Svensson HP; Vrudhula VM; Kerr DE; Hellström I; Hellström KE
    Bioconjug Chem; 1993; 4(1):3-9. PubMed ID: 8431510
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy.
    Senter PD
    FASEB J; 1990 Feb; 4(2):188-93. PubMed ID: 2404820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peroral fluoropyrimidines in chemotherapy for malignant tumors].
    Semiglazova TIu; Gershanovich ML
    Vopr Onkol; 2001; 47(4):388-95. PubMed ID: 11710276
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of prodrugs for enzyme-mediated, tumor-selective therapy.
    Yoon KJ; Potter PM; Danks MK
    Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):107-13. PubMed ID: 15777218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in gene-directed enzyme prodrug therapy: an emerging cancer treatment.
    Both GW
    Curr Opin Mol Ther; 2009 Aug; 11(4):421-32. PubMed ID: 19649987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular therapy for cancer.
    Deisseroth A; Guo D; Wang T; Fujii T; Fu SQ; Cote R; Savinov S; Liu F; Loewe R; Pizzorno G; Austin D; Crystal R; Chung I
    Cancer J Sci Am; 1998 May; 4 Suppl 1():S5-7. PubMed ID: 9619264
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploiting Enzyme Alterations in Cancer for Drug Activation, Drug Delivery, and Nanotherapy.
    Hayashi JY; Tamanoi F
    Enzymes; 2017; 42():153-172. PubMed ID: 29054269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances with monoclonal antibody drug targeting for the treatment of human cancer.
    Koppel GA
    Bioconjug Chem; 1990; 1(1):13-23. PubMed ID: 2095201
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug metabolism by tumours: its nature, relevance and therapeutic implications.
    Michael M; Doherty MM
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):783-803. PubMed ID: 18028025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing anticancer multitarget metal thiosemicarbazone prodrug based on the nature of binding sites of human serum albumin carrier.
    Yang F; Liang H
    Future Med Chem; 2018 Aug; 10(16):1881-1883. PubMed ID: 29925269
    [No Abstract]   [Full Text] [Related]  

  • 20. Prodrug-activating systems in suicide gene therapy.
    Springer CJ; Niculescu-Duvaz I
    J Clin Invest; 2000 May; 105(9):1161-7. PubMed ID: 10791987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.